Blocking immune 'signal two' expands gut tolerance cells, may open new IBD treatments

MedicalXpress | avr. 26, 2026

Weill Cornell Medicine investigators made an unexpected finding about how the immune system normally suppresses inappropriate chronic inflammation in the intestine, potentially opening new avenues for therapies against inflammatory bowel disease (IBD), food allergy and other autoimmune conditions.